Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Beginning Cash Balance (2014 - 2026)

Mesoblast's (MEOBF) quarterly Beginning Cash Balance came in at $161.6 million in Q2 2026, up 156.59% year-over-year from $63.0 million in Q2 2025, and little changed quarter-over-quarter from $161.6 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Beginning Cash Balance (2014 - 2026) Analysis & Trends

Mesoblast has disclosed Beginning Cash Balance across 13 years of filings, most recently posting $161.6 million for Q2 2026.

  • In Q2 2026, Beginning Cash Balance rose 156.59% year-over-year to $161.6 million; the TTM figure through Jun 2026 stood at $161.6 million (up 156.59% YoY), while the FY2026 annual figure was $161.6 million, up 156.59% from the prior year.
  • Beginning Cash Balance came in at $161.6 million for Q2 2026 at Mesoblast, roughly flat from $161.6 million in the prior quarter.
  • In the past five years, Beginning Cash Balance ranged from a high of $161.6 million in Q4 2025 to a low of $60.4 million in Q4 2022.
  • Average Beginning Cash Balance over 5 years is $95.2 million, with a median of $71.3 million recorded in 2023.
  • Year-over-year, Beginning Cash Balance plunged 55.84% in 2022 and jumped 156.59% in 2025.
  • Over 5 years, Beginning Cash Balance stood at $60.4 million in 2022, then advanced by 17.98% to $71.3 million in 2023, then decreased by 11.72% to $63.0 million in 2024, then jumped by 156.59% to $161.6 million in 2025, then changed by 0.0% to $161.6 million in 2026.
  • Per Business Quant data, the three most recent Beginning Cash Balance figures were $161.6 million in Q2 2026, $161.6 million in Q4 2025, and $63.0 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 161.55 Mn
Dec 31, 2025 161.55 Mn
Jun 30, 2025 62.96 Mn
Dec 31, 2024 62.96 Mn
Jun 30, 2024 71.32 Mn
Dec 31, 2023 71.32 Mn
Jun 30, 2023 60.45 Mn
Mar 31, 2023 60.45 Mn
Dec 31, 2022 60.45 Mn
Jun 30, 2022 136.88 Mn
Mar 31, 2022 136.88 Mn
Dec 31, 2021 136.88 Mn
Sep 30, 2021 136.88 Mn
Jun 30, 2021 129.33 Mn
Mar 31, 2021 129.33 Mn
Dec 31, 2020 129.33 Mn
Sep 30, 2020 129.33 Mn
Jun 30, 2020 50.43 Mn
Mar 31, 2020 50.43 Mn
Dec 31, 2019 50.43 Mn